Search
for
Sort by
Research 61–90 of 115
- Co-factors of LIM domains (Clims/Ldb/Nli) regulate corneal homeostasis and maintenance of hair follicle stem cells
- Basement membrane changes in lichen planopilaris
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Collagen XVIIα1 in skin and hair aging: Mechanisms, stem cell niche regulation, and translational strategies
- Successful Treatment of Coexisting Alopecia Areata and Bullous Pemphigoid With Dupilumab: A Case Report
- 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
- Case Report: The First Reported Case of Bullous Lichen Planus-Systemic Lupus Erythematosus Overlap Syndrome
- Life before and beyond blistering: The role of collagen XVII in epidermal physiology
- Characterization of the epidermal-dermal junction in hiPSC-derived skin organoids
- Hair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis
- Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study
- Junctional Epidermolysis Bullosa, Generalized Intermediate Type
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- Clinical Snippets
- Type XVII collagen coordinates proliferation in the interfollicular epidermis
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Generalized atrophic benign epidermolysis bullosa.
- Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
- Thymic Stromal Lymphopoietin in Cutaneous Immune-Mediated Diseases
- Long-Term Survival of Type XVII Collagen Revertant Cells in an Animal Model of Revertant Cell Therapy
- Stem Cell Therapies for Epidermolysis Bullosa Treatment
- Colchicine in Managing Skin Conditions: A Systematic Review
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Effect of cyclosporin on hair-existing area of nude mice